BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21498403)

  • 1. PathScan: a tool for discerning mutational significance in groups of putative cancer genes.
    Wendl MC; Wallis JW; Lin L; Kandoth C; Mardis ER; Wilson RK; Ding L
    Bioinformatics; 2011 Jun; 27(12):1595-602. PubMed ID: 21498403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.
    Wang J; Zhang Y; Shen X; Zhu J; Zhang L; Zou J; Guo Z
    Mol Biosyst; 2011 Apr; 7(4):1158-66. PubMed ID: 21279201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying cancer driver genes in tumor genome sequencing studies.
    Youn A; Simon R
    Bioinformatics; 2011 Jan; 27(2):175-81. PubMed ID: 21169372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.
    Youn A; Simon R
    Bioinformatics; 2012 Jun; 28(12):1555-61. PubMed ID: 22492649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A weighted exact test for mutually exclusive mutations in cancer.
    Leiserson MD; Reyna MA; Raphael BJ
    Bioinformatics; 2016 Sep; 32(17):i736-i745. PubMed ID: 27587696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driver gene mutations based clustering of tumors: methods and applications.
    Zhang W; Flemington EK; Zhang K
    Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation Profile of Resected
    Zhao ZR; Lin YB; Ng CSH; Zhang R; Wu X; Ou Q; Chen W; Zhou WJ; Lin YB; Su XD; Shao YW; Long H
    Oncologist; 2019 Oct; 24(10):1368-1374. PubMed ID: 30872465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
    Tan H; Zhou X
    Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
    Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
    Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
    BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
    Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
    Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
    Imielinski M; Berger AH; Hammerman PS; Hernandez B; Pugh TJ; Hodis E; Cho J; Suh J; Capelletti M; Sivachenko A; Sougnez C; Auclair D; Lawrence MS; Stojanov P; Cibulskis K; Choi K; de Waal L; Sharifnia T; Brooks A; Greulich H; Banerji S; Zander T; Seidel D; Leenders F; Ansén S; Ludwig C; Engel-Riedel W; Stoelben E; Wolf J; Goparju C; Thompson K; Winckler W; Kwiatkowski D; Johnson BE; Jänne PA; Miller VA; Pao W; Travis WD; Pass HI; Gabriel SB; Lander ES; Thomas RK; Garraway LA; Getz G; Meyerson M
    Cell; 2012 Sep; 150(6):1107-20. PubMed ID: 22980975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.
    Centeno I; Blay P; Santamaría I; Astudillo A; Pitiot AS; Osorio FG; González-Arriaga P; Iglesias F; Menéndez P; Tardón A; Freije JM; Balbín M
    BMC Cancer; 2011 May; 11():172. PubMed ID: 21575252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Alteration During Metastasis of Lung Adenocarcinoma.
    Tan Q; Cui J; Huang J; Ding Z; Lin H; Niu X; Li Z; Wang G; Luo Q; Lu S
    Cell Physiol Biochem; 2016; 38(2):469-86. PubMed ID: 26828653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
    Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of somatic alterations in stage I lung adenocarcinomas by next-generation sequencing.
    Zhao Y; Yang J; Chen Z; Gao Z; Zhou F; Li X; Li J; Shi S; Feng X; Sun N; Yao R; Zhou C; Chang S; Li M; Zhou Y; Li L; Zhang X; He J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):289-98. PubMed ID: 24449147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.